Vanguard Asset Management’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.61M Buy
99,657
+18,419
+23% +$423K ﹤0.01% 1665
2026
Q2
$1.8M Buy
81,238
+7,930
+11% +$147K ﹤0.01% 1602
2026
Q1
$1.33M Buy
+73,308
New +$1.26M ﹤0.01% 1658

Other funds holding DYN

Vanguard Asset Management's DYN Position: Q3 2026 in Review

Vanguard Asset Management increased its Dyne Therapeutics (DYN) stake by 23% in Q3 2026, buying an estimated $423K and bringing the position to 99,657 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Vanguard Asset Management first reported a position in DYN in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.8M in Q2 2026. 260 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • Vanguard Asset Management held 99,657 shares of Dyne Therapeutics worth $1.61M as of Q3 2026.
  • Vanguard Asset Management bought 18,419 Dyne Therapeutics shares in Q3 2026, an estimated $423K.
  • Dyne Therapeutics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1665 holding.
  • Vanguard Asset Management first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Dyne Therapeutics position peaked at $1.8M in Q2 2026.
  • 260 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.